Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Durvalumab with Chemoradiation Therapy for Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Comparison of Sotorasib versus Docetaxel in Previously Treated Non-Small Cell Lung Cancer Patients with KRAS p.
Not recruiting
Investigated Drugs:
+2
Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
Not recruiting
Investigated Diseases:Investigated Drugs:
+6
Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+8
Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+3
Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+3